{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:06:17Z","timestamp":1790103977383,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2021-12374537"],"award-info":[{"award-number":["RF-2021-12374537"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58122-9","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:41:04Z","timestamp":1781793664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a portable device for the detection of anti-PEG antibodies in human plasma"],"prefix":"10.1038","volume":"16","author":[{"given":"Laura","family":"Pasquardini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzio","family":"Cennamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Canteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Vanzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marten","family":"Beeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Gualtierotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Pasquale","family":"Renzullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Tavoletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Schiavone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Suffritti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Zeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"58122_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/BTT.S29948","volume":"7","author":"R Reuss","year":"2013","unstructured":"Reuss, R. PEGylated interferon beta-1a in the treatment of multiple sclerosis\u2014An update. Biol. Targets Ther. 7, 131\u2013138 (2013).","journal-title":"Biol. Targets Ther."},{"key":"58122_CR2","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41565-025-01925-0","volume":"20","author":"MA Dobrovolskaia","year":"2025","unstructured":"Dobrovolskaia, M. A. Better the devil you know than the devil you don\u2019t\u2014PEG challenges in nanomedicine. Nat. Nanotechnol. 20, 580\u2013583 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"58122_CR3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41467-017-00622-4","volume":"8","author":"C-J Chang","year":"2017","unstructured":"Chang, C.-J. et al. A genome-wide association study identifies a novel susceptibility locus for the immunogenicity of polyethylene glycol. Nat. Commun. 8, 522 (2017).","journal-title":"Nat. Commun."},{"key":"58122_CR4","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.chembiol.2019.02.001","volume":"26","author":"A Moreno","year":"2019","unstructured":"Moreno, A. et al. Anti-PEG antibodies inhibit the anticoagulant activity of PEGylated aptamers. Cell Chem. Biol. 26, 634-644.e3 (2019).","journal-title":"Cell Chem. Biol."},{"key":"58122_CR5","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1016\/j.vaccine.2023.06.009","volume":"41","author":"GT Kozma","year":"2023","unstructured":"Kozma, G. T. et al. Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG. Vaccine 41, 4561\u20134570 (2023).","journal-title":"Vaccine"},{"key":"58122_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2024.100497","volume":"19","author":"BA Barta","year":"2024","unstructured":"Barta, B. A. et al. Comirnaty-induced cardiopulmonary distress and other symptoms of complement-mediated pseudo-anaphylaxis in a hyperimmune pig model: Causal role of anti-PEG antibodies. Vaccine X 19, 100497 (2024).","journal-title":"Vaccine X"},{"key":"58122_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41577-022-00825-x","volume":"23","author":"Y Ju","year":"2023","unstructured":"Ju, Y. et al. Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines. Nat. Rev. Immunol. 23, 135\u2013136 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"58122_CR8","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jtha.2023.03.011","volume":"21","author":"B Pezeshkpoor","year":"2023","unstructured":"Pezeshkpoor, B. et al. Antidrug antibodies against the polyethylene glycol moiety inhibit the procoagulant activity of therapeutic polyethylene glycolated factor VIII. J. Thromb. Haemost. 21, 1503\u20131514 (2023).","journal-title":"J. Thromb. Haemost."},{"key":"58122_CR9","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1111\/hae.14864","volume":"29","author":"J Oldenburg","year":"2023","unstructured":"Oldenburg, J. et al. Cases of less-than-expected FVIII activity in previously treated patients during post-marketing surveillance of N8-GP. Haemophilia 29, 1475\u20131482 (2023).","journal-title":"Haemophilia"},{"key":"58122_CR10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/hae.14294","volume":"27","author":"ME Mancuso","year":"2021","unstructured":"Mancuso, M. E. et al. PROTECT VIII kids extension study: Long-term safety and efficacy of BAY 94\u20139027 (damoctocog alfa pegol) in children with severe haemophilia A. Haemophilia 27, 434\u2013444 (2021).","journal-title":"Haemophilia"},{"key":"58122_CR11","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s40265-019-01190-1","volume":"79","author":"J Paik","year":"2019","unstructured":"Paik, J. & Deeks, E. D. Correction to: Damoctocog Alfa Pegol: A review in haemophilia A. Drugs 79, 1495 (2019).","journal-title":"Drugs"},{"key":"58122_CR12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/hae.14786","volume":"29","author":"Y Nakajima","year":"2023","unstructured":"Nakajima, Y. et al. Intra-articular haemorrhage caused by reduced recovery of PEGylated recombinant factor VIII due to an anti-PEG antibody developed after mRNA-1273 SARS-CoV-2 vaccination in haemophilia A. Haemophilia 29, 935\u2013938 (2023).","journal-title":"Haemophilia"},{"key":"58122_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1182\/bloodadvances.2022008989","volume":"7","author":"C Valsecchi","year":"2023","unstructured":"Valsecchi, C. et al. Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination. Blood Adv. 7, 174\u2013177 (2023).","journal-title":"Blood Adv."},{"key":"58122_CR14","doi-asserted-by":"publisher","first-page":"11804","DOI":"10.1021\/acs.analchem.6b03437","volume":"88","author":"Q Yang","year":"2016","unstructured":"Yang, Q. et al. Analysis of pre-existing IgG and IgM antibodies against polyethylene glycol (PEG) in the general population. Anal. Chem. 88, 11804\u201311812 (2016).","journal-title":"Anal. Chem."},{"key":"58122_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.xphs.2023.11.001","volume":"113","author":"SA Gaballa","year":"2024","unstructured":"Gaballa, S. A. et al. Treatment-induced and pre-existing anti-peg antibodies: Prevalence, clinical implications, and future perspectives. J. Pharm. Sci. 113, 555\u2013578 (2024).","journal-title":"J. Pharm. Sci."},{"key":"58122_CR16","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1039\/D3NH00198A","volume":"8","author":"MFS Deuker","year":"2023","unstructured":"Deuker, M. F. S., Mail\u00e4nder, V., Morsbach, S. & Landfester, K. Anti-PEG antibodies enriched in the protein corona of PEGylated nanocarriers impact the cell uptake. Nanoscale Horizons 8, 1377\u20131385 (2023).","journal-title":"Nanoscale Horizons"},{"key":"58122_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2020.106678","volume":"102","author":"L Hong","year":"2020","unstructured":"Hong, L., Wang, Z., Wei, X., Shi, J. & Li, C. Antibodies against polyethylene glycol in human blood: A literature review. J. Pharmacol. Toxicol. Methods 102, 106678 (2020).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"58122_CR18","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s11095-016-1961-x","volume":"33","author":"C Lubich","year":"2016","unstructured":"Lubich, C. et al. The mystery of antibodies against polyethylene glycol (PEG)\u2014What do we know?. Pharm. Res. 33, 2239\u20132249 (2016).","journal-title":"Pharm. Res."},{"key":"58122_CR19","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1016\/j.jtha.2023.07.019","volume":"21","author":"A Hillarp","year":"2023","unstructured":"Hillarp, A. et al. Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII. J. Thromb. Haemost. 21, 2771\u20132775 (2023).","journal-title":"J. Thromb. Haemost."},{"key":"58122_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/cncr.22739","volume":"110","author":"JK Armstrong","year":"2007","unstructured":"Armstrong, J. K. et al. Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients. Cancer 110, 103\u2013111 (2007).","journal-title":"Cancer"},{"key":"58122_CR21","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.4155\/bio.15.112","volume":"7","author":"M Krishna","year":"2015","unstructured":"Krishna, M. et al. Development and characterization of antibody reagents to assess anti-PEG IgG antibodies in clinical samples. Bioanalysis 7, 1869\u20131883 (2015).","journal-title":"Bioanalysis"},{"key":"58122_CR22","doi-asserted-by":"publisher","first-page":"9958","DOI":"10.1021\/acsnano.8b04016","volume":"12","author":"SS A\u0107imovi\u0107","year":"2018","unstructured":"A\u0107imovi\u0107, S. S. et al. Antibody-antigen interaction dynamics revealed by analysis of single-molecule equilibrium fluctuations on individual plasmonic nanoparticle biosensors. ACS Nano 12, 9958\u20139965 (2018).","journal-title":"ACS Nano"},{"key":"58122_CR23","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1021\/jacsau.5c00852","volume":"5","author":"C Pav\u00f3n","year":"2025","unstructured":"Pav\u00f3n, C. et al. The role of structural dispersity of polymer brushes in determining the colloidal stability of core-shell nanoparticles and their interaction with anti-PEG antibodies. JACS Au 5, 4519\u20134529 (2025).","journal-title":"JACS Au"},{"key":"58122_CR24","doi-asserted-by":"publisher","first-page":"8217","DOI":"10.1021\/acs.analchem.7b02447","volume":"89","author":"P Zhang","year":"2017","unstructured":"Zhang, P. et al. Sensitive and quantitative detection of anti-poly(ethylene glycol) (PEG) antibodies by methoxy-PEG-coated surface plasmon resonance sensors. Anal. Chem. 89, 8217\u20138222 (2017).","journal-title":"Anal. Chem."},{"issue":"Suppl 6","key":"58122_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hae.14046","volume":"26","author":"A Srivastava","year":"2020","unstructured":"Srivastava, A. et al. WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia 26(Suppl 6), 1\u2013158 (2020).","journal-title":"Haemophilia"},{"key":"58122_CR26","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1111\/hae.14402","volume":"28","author":"J O\u2019Hara","year":"2022","unstructured":"O\u2019Hara, J., Noone, D. & Watt, M. Relationship between bleeding episodes, health-related quality of life and direct costs in adults with severe haemophilia A: Secondary analyses from the CHESS study. Haemophilia 28, e117\u2013e120 (2022).","journal-title":"Haemophilia"},{"key":"58122_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13023-023-02690-w","volume":"18","author":"L Young","year":"2023","unstructured":"Young, L. et al. The impact of bleeding event frequency on health-related quality of life and work productivity outcomes in a European cohort of adults with haemophilia A: Insights from the CHESS II study. Orphanet J. Rare Dis. 18, 227 (2023).","journal-title":"Orphanet J. Rare Dis."},{"key":"58122_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s42004-020-00369-y","volume":"3","author":"JT Huckaby","year":"2020","unstructured":"Huckaby, J. T. et al. Structure of an anti-PEG antibody reveals an open ring that captures highly flexible PEG polymers. Commun. Chem. 3, 124 (2020).","journal-title":"Commun. Chem."},{"key":"58122_CR29","doi-asserted-by":"publisher","first-page":"17463","DOI":"10.1021\/acsami.8b02854","volume":"10","author":"C Zhang","year":"2018","unstructured":"Zhang, C. et al. Investigation on the linker length of synthetic zwitterionic polypeptides for improved nonfouling surfaces. ACS Appl. Mater. Interfaces 10, 17463\u201317470 (2018).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"58122_CR30","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.apsusc.2018.08.136","volume":"462","author":"A Al-Ani","year":"2018","unstructured":"Al-Ani, A. et al. The influence of PEG-thiol derivatives on controlling cellular and bacterial interactions with gold surfaces. Appl. Surf. Sci. 462, 980\u2013990 (2018).","journal-title":"Appl. Surf. Sci."},{"key":"58122_CR31","doi-asserted-by":"publisher","first-page":"18740","DOI":"10.1038\/s41598-019-55248-x","volume":"9","author":"N Cennamo","year":"2019","unstructured":"Cennamo, N. et al. D-shaped plastic optical fibre aptasensor for fast thrombin detection in nanomolar range. Sci. Rep. 9, 18740 (2019).","journal-title":"Sci. Rep."},{"key":"58122_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/jctb.280530219","volume":"53","author":"A Taylor","year":"1992","unstructured":"Taylor, A. Practical surface analysis, 2nd edn., vol I, auger and X-ray photoelectron spectroscopy. Edited by D. Briggs, M. P. Seah, John Wiley, New York, 1990, 657 pp., price: \u00a386.50. ISBN 0471 92081 9. J. Chem. Technol. Biotechnol. 53, 215 (1992).","journal-title":"J. Chem. Technol. Biotechnol."},{"key":"58122_CR33","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1021\/la101858y","volume":"27","author":"E Briand","year":"2011","unstructured":"Briand, E. et al. Chemical modifications of Au\/SiO2 template substrates for patterned biofunctional surfaces. Langmuir 27, 678\u2013685 (2011).","journal-title":"Langmuir"},{"key":"58122_CR34","doi-asserted-by":"publisher","first-page":"04B304","DOI":"10.1116\/1.4967216","volume":"11","author":"A Rafati","year":"2016","unstructured":"Rafati, A., Shard, A. G. & Castner, D. G. Multitechnique characterization of oligo(ethylene glycol) functionalized gold nanoparticles. Biointerphases 11, 04B304 (2016).","journal-title":"Biointerphases"},{"key":"58122_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0168-3659(02)00138-4","volume":"82","author":"TW Kim","year":"2002","unstructured":"Kim, T. W. et al. The role of non-ionic surfactants on cationic lipid mediated gene transfer. J. Control. Release 82, 455\u2013465 (2002).","journal-title":"J. Control. Release"},{"key":"58122_CR36","doi-asserted-by":"publisher","first-page":"14976","DOI":"10.1038\/s41598-021-94431-x","volume":"11","author":"M Beeg","year":"2021","unstructured":"Beeg, M. et al. Surface plasmon resonance unveils important pitfalls of enzyme-linked immunoassay for the detection of anti-infliximab antibodies in patients\u2019 sera. Sci. Rep. 11, 14976 (2021).","journal-title":"Sci. Rep."},{"key":"58122_CR37","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"58122_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.softx.2019.100282","volume":"10","author":"G Speranza","year":"2019","unstructured":"Speranza, G. & Canteri, R. RxpsG a new open project for Photoelectron and Electron Spectroscopy data processing. SoftwareX 10, 100282 (2019).","journal-title":"SoftwareX"},{"key":"58122_CR39","unstructured":"R Core Team. R project. R: A language and environment for statistical computing. R Foundation for Statistical Computing https:\/\/www.r-project.org\/ (2021)."},{"key":"58122_CR40","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1038\/s41598-018-37950-4","volume":"9","author":"M Beeg","year":"2019","unstructured":"Beeg, M. et al. A surface plasmon resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies. Sci. Rep. 9, 2064 (2019).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58122-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58122-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58122-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:33:13Z","timestamp":1788820393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58122-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58122"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58122-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was part of a pharmacological observational study, named \u201cAnti-PEG antibodies and their pathophysiological role in the personalized management of patients with hemophilia\u201d, funded by the Italian Minister of Health. Ethics Committee approval was obtained on 26th January 2023 (ID 3289, study number 6513) from the Comitato Etico Milano Area 2 (approval number 24_2023bis). The study was carried out in conformity with the 2013 revision of the Declaration of Helsinki and the code of Good Clinical Practice. Consecutive adult persons affected with severe\/moderate hemophilia A referring at the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center of Fondazione IRCCS Ca\u2019 Granda, Ospedale Maggiore Policlinico, Milano, Italy were asked to participate in the study and signed the informed consent.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27978"}}